Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis

NCT04789850 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Systemic Sclerosis

Interventions

DRUG: Itacitinib
DRUG: Placebo

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]